The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Earlier this year the Dept. of Health and Human Services (HHS) released 252 pages of documents confirming for the first time it recommended to the DEA to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.
The documents explained that cannabis “has a currently accepted medical use in treatment in the United States” and that it has a “potential for abuse less than the drugs or other substances in Schedules I and II."
Now, investors seem optimistic about potential regulatory changes that could benefit the cannabis industry.
Pro tip: Learn all about the future of the cannabis industry at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following this link, and access a 20% discount using the code JAVI20.
Here’s how some of the top US and Canadian cannabis stocks are trading at the moment of writing on Tuesday:
- Curaleaf Holdings Inc‘s CURLF shares are trading 17.78% higher at $5.94 per share.
- Green Thumb Industries Inc‘s GTBIF shares are trading 21.23% higher at $15.22 per share.
- Cresco Labs Inc‘s CRLBF, shares are trading 14.68% higher at $2.5 per share.
- Verano Holdings Corp‘s VRNOF shares are trading 17.62% higher at $5.94 per share.
- Trulieve Cannabis Corp‘s TRUL TCNNF shares are trading 27.12% higher at $13.22 per share.
- The Cannabist Company Holdings Inc’s CBST CBSTF 3LP shares are trading 29.95% higher at $0.3697 per share.
- WM Technology, Inc. MAPS shares are trading 38.1201% higher at $1.4400 per share.
- Canopy Growth Corporation WEED CGC shares are trading 35.34% higher at $11.26 per share.
- Tilray Brands Inc‘s TLRY shares are trading 29.9379% higher at $2.2999 per share.
- Aurora Cannabis, Inc. ACB shares are trading 22.94% higher at $7.77per share.
Here’s how some of the best-performing cannabis ETFs are trading at the moment of writing on Tuesday:
- AdvisorShares Pure US Cannabis ETF‘s MSOS shares are trading 21.01% higher at $10.91 per share.
- Amplify Alternative Harvest ETF's MJ shares are trading 17.62% higher at $4.5050 per share.
- AdvisorShares MSOS 2x Daily ETF’s MSOX shares are trading 43.26% higher at $6.92 per share.
- AdvisorShares Pure Cannabis ETF‘s YOLO shares are trading 17.15% higher at $4.4399 per share.
- Amplify Seymour Cannabis ETF‘s CNBS shares are trading 20.27% higher at $6.17 per share.
- Amplify U.S. Alternative Harvest ETF's MJUS shares are trading 18.79% higher at $2.3401 per share.
Pro tip: Learn all about the future of the cannabis industry at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following this link, and access a 20% discount using the code JAVI20.here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!